President Trump has signed an executive order to expand research into psychedelic drugs for mental health treatment. Dr. Marty Makary, commissioner of the Food and Drug Administration, joins CBS News to discuss.
The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects.